<div id="readability-page-1">05:30 PM EST, 01/20/2026 (MT Newswires) -- BioAge Labs ( BIOA ) reported late Tuesday that it plans to launch a public offering of up to $75 million of common shares.Underwriters will be given a 30-day option to buy an additional $11.3 million of shares of its common stock, the company said.The biopharma company said it plans to use the proceeds from offering, along with its existing cash, to finance the advancement of its product candidates, including lead candidate BGE-102, for debt reduction and general corporate purposes, among others.Shares of the company fell more than 5% in recent after-hours activity. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.</div>

BioAge Labs plans a public offering of up to $75 million in common shares, with underwriters having a 30-day option for an additional $11.3 million. The funds will support the advancement of product candidates, including BGE-102, debt reduction, and general corporate purposes. Following the announcement, shares fell over 5% in after-hours trading.

fidelity

Ark Genomic Revolution ETF

First Trust NYSE Arca Biotech Index Fd

Health Care Select Sector SPDR

VG Health

iShares US Pharma

VanEck Biotech ETF

iShares Global Healthcare

SPDR S&P Biotech

iShares Biotechnology ETF

ALPS Medical Breakthrough

Proshares Ultra Nasdaq Biotech

Invesco Biotechnology & Genome ETF

BioAge Labs

BioAge Labs Proposes Public Offering Worth $75 Million